Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Cash flows from operating activities:
Net loss	$ (66,489)	$ (49,375)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	276	589
Share-based compensation	8,368	8,560
Amortization of premium and discount on marketable securities	(1,673)	(1,651)
ROU asset amortization	1,196	1,164
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	5,116	(4,857)
Accounts payable	(664)	(1,841)
Accrued expenses	5,096	3,773
Operating lease liability	(369)	(1,217)
Net cash used in operating activities	(49,143)	(44,855)
Cash flows from investing activities:
Purchases of marketable securities	(194,557)	(88,158)
Proceeds from sale or maturities of marketable securities	101,276	134,974
Purchase of property and equipment	(25)	(44)
Net cash (used in) provided by investing activities	(93,306)	46,772
Cash flows from financing activities:
Proceeds from issuance of common stock and warrants	137,999	18,113
Issuance costs from issuance of common stock	(8,638)	(543)
Proceeds from exercise of stock options	1,275	0
Taxes paid related to net shares settlement of RSUs	(1,027)	(232)
Net cash provided by financing activities	129,609	17,338
Net change in cash, cash equivalents and restricted cash	(12,840)	19,255
Cash, cash equivalents and restricted cash at beginning of year	44,051	24,228
Cash, cash equivalents and restricted cash at end of period	31,211	44,051
Reconciliation of cash, cash equivalents and restricted cash to the Consolidated Balance Sheets
Cash and cash equivalents	30,643	43,483
Restricted cash	568	568
Total cash, cash equivalents and restricted cash	31,211	44,051
Supplemental disclosure of cash flow information
Unrealized gain (loss) on marketable securities	$ 70	$ 173